Olympus Corp. 7733
TSE · Japan · Health Technology
¥2,008.50-6.00 (-0.30%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Olympus Corporation (Olympus), a global MedTech company, today announced full commercial launch in the U.S. and Canada of the POWERSEAL™ Open Extended Jaw Sealer/Divider indicated for use in key surgical specialties that include colorectal, gynecological, thoracic, urological and vascular.
Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, today announced an exclusive global distribution agreement with Endocision for a portable, single-use flexible cryocatheter system.
Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, today reported first quarter fiscal 2027 results for the three months ended June 30, 2026. First quarter revenue was 240.4 billion Japanese yen, up 16% year on year and up 5% in constant currency. Strong momentum in the Gastrointestinal Solutions (GIS) business drove growth. While the Surgical and Interventional Solutions (SIS) business was affected by voluntary ship holds, core franchises Urol
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.